10:16 AM EST - BioVaxys Technology Corp : Announces that, further to its news release dated November 14, 2025, it has issued 1,792,387 common shares in the capital of the Company, at a deemed value of $0.23 per Settlement Share, in full and final settlement of accrued and outstanding indebtedness in the aggregate amount of $412,249. BioVaxys Technology Corp
shares C.BIOV are trading up $0.04 at $0.25.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=BIOV%3ACNX&qmodStoryID=7390365000169906
